BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 10885368)

  • 1. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?
    Esparza J; Bhamarapravati N
    Lancet; 2000 Jun; 355(9220):2061-6. PubMed ID: 10885368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An HIV vaccine: how and when?
    Esparza J
    Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thailand attacks AIDS with two-pronged approach.
    Berman J
    Lancet; 1999 May; 353(9164):1600. PubMed ID: 10334271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV vaccines: a global perspective.
    Esparza J; Osmanov S
    Curr Mol Med; 2003 May; 3(3):183-93. PubMed ID: 12699356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000.
    AIDS; 2001 May; 15(7):W27-44. PubMed ID: 11399975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HIV vaccine: how long must we wait?
    Lancet; 1998 Oct; 352(9137):1323. PubMed ID: 9802261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing HIV vaccines for developing countries.
    Abrams S
    Harv AIDS Rev; 1995; ():17-9. PubMed ID: 12319991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Past, present and future of HIV vaccine trials in developing countries.
    Esparza J; Osmanov S; Pattou-Markovic C; Touré C; Chang ML; Nixon S
    Vaccine; 2002 May; 20(15):1897-8. PubMed ID: 11983240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FHI to oversee AIDS vaccine trials.
    Netw Res Triangle Park N C; 1994 Feb; 14(3):2. PubMed ID: 12287505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remarks spoken before the audience at the final conference plenary session, entitled: "Future directions," at the International Conference on Advances in AIDS Vaccine Development. Fourth annual meeting of the National Cooperative Vaccine Development Groups for AIDS.
    Nzila N
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1521-2. PubMed ID: 1466995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fresh injection of interest for vaccines.
    AIDS Anal Afr; 1998 Feb; 8(1):3, 6. PubMed ID: 12293289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.
    Girard MP; Osmanov S; Assossou OM; Kieny MP
    Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing HIV transmission in "priority" countries.
    Finger WR
    Netw Res Triangle Park N C; 1993 May; 13(4):18-21. PubMed ID: 12344871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/AIDS treatment and HIV vaccines for Africa.
    Weidle PJ; Mastro TD; Grant AD; Nkengasong J; Macharia D
    Lancet; 2002 Jun; 359(9325):2261-7. PubMed ID: 12103304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The WHO statement on strategies of HIV vaccinations: field trials in developing countries should await studies of the effects].
    Lennholm B
    Lakartidningen; 1993 Mar; 90(13):1245-6. PubMed ID: 8469070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002.
    Chang ML; Vitek C; Esparza J;
    AIDS; 2003 Oct; 17(15):W1-10. PubMed ID: 14523295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV vaccine development and evaluation: realistic expectations.
    Heyward WL; MacQueen KM; Goldenthal KL
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S205-10. PubMed ID: 9814945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines trials and treatment.
    Adler MW
    SAfAIDS News; 1997 Jun; 5(2):6. PubMed ID: 12222364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research.
    Lehner T; Hoelscher M; Clerici M; Gotch F; Pedneault L; Tartaglia J; Gray C; Mestecky J; Sattentau Q; van de Wijgert J; Toure C; Osmanov S; Schmidt RE; Debre P; Romaris M; Hoeveler A; Di Fabio S
    Vaccine; 2005 Dec; 23(48-49):5551-6. PubMed ID: 16153752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenges of HIV vaccine development and testing.
    Burgers WA; Williamson C
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):277-91. PubMed ID: 15778116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.